PADCEV

Google image searchProduct monograph

Active ingredient

enfortumab vedotin, 20 MG/VIAL

DIN: 02521903

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: SEAGEN INC.

Date: 20-DEC-2021

ATC:

Search on Google